Bausch Health
BHC
#3695
Rank
C$4.05 B
Marketcap
$11.00
Share price
0.39%
Change (1 day)
11.51%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$3.61

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$3.80. In 2022 the company made an earnings per share (EPS) of -$0.89 an increase over its 2021 EPS that were of -$3.81.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.61305.65%
2022-$0.89-76.64%
2021-$3.8168.45%
2020-$2.26-68.91%
2019-$7.27-57.11%
2018-$16.94-272.22%
2017$9.84-199.29%
2016-$9.91798.7%
2015-$1.10-128.31%
2014$3.89-204.62%
2013-$3.72602.7%
2012-$0.53-171.15%
2011$0.74-143.96%
2010-$1.69-206.57%
2009$1.59-11.2%
2008$1.792.46%
2007$1.75-7.58%
2006$1.89-14.29%
2005$2.2154%
2004$1.43-500%
2003-$0.36-141.67%
2002$0.86-4.76%
2001$0.90-175%
2000-$1.20-268%
1999$0.7214.94%
1998$0.6220.83%
1997$0.5253.83%
1996$0.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.43-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.39-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA